Merck (MSD) has reported positive results from the Phase III PNEU-PATH and PNEU-DAY trials of its investigational 15-valent pneumococcal conjugate vaccine, V114, against pneumococcal disease.…
Pfizer and BioNTech have begun combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against Covid-19 in Japan. The trials will…
Biopharma firm Aptinyx has reported positive results from the first Phase II study of its new NMDA receptor modulator, NYX-783,…
Canada-based MediPharm Labs has begun a clinical trial to research and analyse the effectiveness of its cannabis-derived medical products and…
Biopharmaceutical company VelosBio has dosed the first patient in a Phase II trial of investigational drug VLS-101 in patients with…
A potential Covid-19 vaccine being developed by China National Biotech Group (CNBG) unit Beijing Institute of Biologic Products demonstrated to…
Smooth visibility from the place of production to the ultimate destination must be the new standard for vaccine delivery. The…
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…
Define.xml is the metadata that describes the content and formatting of submission datasets and the case report tabulation data. It’s…
